- Retraction Note
- Open Access
Retraction Note: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis
Journal of Experimental & Clinical Cancer Research volume 41, Article number: 351 (2022)
Retraction Note: J Exp Clin Cancer Res 35, 105 (2016)
The authors have retracted this article due to irregularities found in figures 3G and J, 4G and J, 5G and J and 6F. The authors therefore no longer have confidence in the reliability of their results. Xiaoyan Bai has not explicitly stated whether they agree to this retraction notice. Jianwei Tian, Liping Hu, Xiao Li, Jian Geng and Meng Dai have not responded to any correspondence from the editor/publisher about this retraction.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Tian, J., Hu, L., Li, X. et al. Retraction Note: MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis. J Exp Clin Cancer Res 41, 351 (2022). https://doi.org/10.1186/s13046-022-02548-2